Total assets · 2011–2025
Regeneron Pharmaceuticals total assets
$40.6B+7.4% · FY2025
Regeneron Pharmaceuticals (REGN) reported $40.6B in total assets for fiscal 2025, +7.4% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $40.6B | +7.4% | Open → |
| FY20242024-12-31 | $37.8B | +14.1% | Open → |
| FY20232023-12-31 | $33.1B | +13.2% | Open → |
| FY20222022-12-31 | $29.2B | +14.9% | Open → |
| FY20212021-12-31 | $25.4B | +48.2% | Open → |
| FY20202020-12-31 | $17.2B | +15.9% | Open → |
| FY20192019-12-31 | $14.8B | +26.2% | Open → |
| FY20182018-12-31 | $11.7B | +33.9% | Open → |
| FY20172017-12-31 | $8.8B | +25.7% | Open → |
| FY20162016-12-31 | $7.0B | +24.3% | Open → |
| FY20152015-12-31 | $5.6B | +46.2% | Open → |
| FY20142014-12-31 | $3.8B | +30.0% | Open → |
| FY20132013-12-31 | $3.0B | +41.8% | Open → |
| FY20122012-12-31 | $2.1B | +57.2% | Open → |
| FY20112011-12-31 | $1.3B | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +27.7%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regeneron Pharmaceuticals total assets |url=https://companiesranked.com/en/company/regeneron-pharmaceuticals/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regeneron Pharmaceuticals total assets. CompaniesRanked. https://companiesranked.com/en/company/regeneron-pharmaceuticals/total-assetsBibTeX
@misc{companiesranked-en-company-regeneron-pharmaceuticals-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Regeneron Pharmaceuticals total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regeneron-pharmaceuticals/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000872589-26-000025 · July 30, 2026
{{cite web |title=Regeneron Pharmaceuticals total assets — 10-Q (0000872589-26-000025) |url=https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/regn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-30}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.